XOMA Royalty (XOMA) Tax Rate (2011 - 2026)
XOMA Royalty's (XOMA) quarterly Tax Rate came in at 0.02% in Q1 2026, up 110.73% quarter-over-quarter from 0.21% in Q4 2025.
XOMA Royalty (XOMA) Tax Rate (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed Tax Rate across 9 years of filings, most recently posting 0.02% for Q1 2026.
- Tax Rate for Q1 2026 came in at 0.02%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 1.75% (changed N/A YoY), and the FY2025 annual result was 47.47%, down 836805.0% from the prior year.
- Tax Rate came in at 0.02% for Q1 2026 at XOMA Royalty, up from 0.21% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.35% in Q3 2025 to a low of 0.21% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -57.14% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 5.61% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -6.79% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 17.68% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.02% |
| Mar 31, 2026 | 0.02% |
| Dec 31, 2025 | -0.21% |
| Dec 31, 2025 | -0.21% |
| Sep 30, 2025 | 0.35% |
| Sep 30, 2025 | 0.35% |
| Dec 31, 2021 | 0.30% |
| Dec 31, 2021 | 0.30% |
| Dec 31, 2020 | 0.11% |
| Dec 31, 2020 | 0.11% |
| Sep 30, 2020 | 2.41% |
| Sep 30, 2020 | 2.41% |
| Jun 30, 2020 | -0.74% |
| Jun 30, 2020 | -0.74% |
| Mar 31, 2020 | 24.28% |
| Mar 31, 2020 | 24.28% |
| Dec 31, 2018 | 3.15% |
| Dec 31, 2018 | 3.15% |
| Dec 31, 2017 | 3.23% |
| Dec 31, 2017 | 3.23% |